AOD-9604
Targeted Fat-Metabolism
WHAT IT IS:
A component of Human Growth Hormone that is responsible for fat metabolism and designed to support fat breakdown.
WHY YOU NEED IT:
Fat-Focused Metabolism Without Growth-Hormone Side Effects
Important for patients seeking weight loss support for stubborn fatty areas
Supports patients who want fat-metabolism help without hormone-related side effects
Good for patients pursuing body recomposition alongside healthy diet and exercise
Great for patients who prefer a daily microdosing approach
Important for patients who want a well-tolerated adjunct to a healthy lifestyle
HOW IT HELPS:
Sustainable fat loss depends on how efficiently the body mobilizes and burns stored fat. AOD-9604 was developed to target that specific process of burning fat without triggering other growth-hormone effects.
A Targeted Growth-Hormone Fragment
AOD-9604 corresponds to one small part of Human Growth Hormone — the part associated with fat metabolism. Research suggests it may stimulate lipolysis (fat breakdown) and limit lipogenesis (new fat formation).
Designed to Avoid GH Drawbacks
Unlike full growth hormone, AOD-9604 does not appear to raise IGF-1 or interfere with glucose metabolism, which is part of its appeal as a fat-focused option. It is most effective when paired with a calorie-conscious diet and regular activity.
The Clinical Trials
AOD-9604 has an unusually large safety database — studied in over 900 participants across multiple controlled trials — and was generally well tolerated. Reported side effects are rare and mild, such as injection-site redness or temporary headache. Newer research has begun exploring potential roles in cartilage and joint support.
Who Should Not Use AOD-9604
AOD-9604 is not appropriate for women who are pregnant or breastfeeding or patients with a known hypersensitivity, and should be used cautiously in patients with significant medical conditions. It is banned by the World Anti-Doping Agency, due to its presumed effectiveness.
DOSAGE:
Approach: Consistent daily microdosing is favored over higher doses, which have not shown greater benefit.
Titration: Cycle length (commonly 12–16 weeks with breaks) and dosing should be individualized and supervised by a physician; reconstitute with bacteriostatic water using sterile technique.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
